Johnson & Johnson: Up to 200,000 Ebola Vaccine Regimens Available as Part of WHO Program
May 13 2021 - 8:57AM
Dow Jones News
By Dave Sebastian
Johnson & Johnson said up to 200,000 Ebola vaccine regimens
will be made available as part of a World Health Organization early
access clinical program underway in Sierra Leone.
The WHO and the Sierra Leone government have started
administering the vaccine regimen as part of an effort to prevent
the further spread of Ebola in West Africa, the company said
Thursday.
J&J said its vaccine regimen, developed with Bavarian Nordic
A/S, also received prequalification from the WHO. The regimen is
being donated to the WHO, the company said.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
May 13, 2021 08:42 ET (12:42 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024
